Rikke Holm Hansen

Medicine & Life Sciences

1. Dimethyl Fumarate 100%
2. Multiple Sclerosis 82%
3. Chronic Progressive Multiple Sclerosis 65%
4. Helper-Inducer T-Lymphocytes 62%
5. Relapsing-Remitting Multiple Sclerosis 57%
6. T-Lymphocytes 47%
7. B-Lymphocytes 27%
8. Cerebrospinal Fluid 25%
9. ofatumumab 24%
10. Mucosal-Associated Invariant T Cells 23%
11. Cladribine 20%
12. Myelin Basic Protein 15%
13. Huntington Disease 15%
14. Therapeutics 15%
15. B-Lymphocyte Subsets 14%
16. Intermediate Filaments 13%
17. Randomized Controlled Trials 12%
18. Flow Cytometry 12%
19. Cell Movement 11%
20. Fumarates 10%
21. Inflammation 10%
22. Placebos 10%
23. Biomarkers 10%
24. T-Lymphocyte Subsets 10%
25. Cytokines 9%
26. Central Nervous System 9%
27. Light 8%
28. Interleukin-7 8%
29. Interleukin-17 7%
30. Regulatory T-Lymphocytes 7%
31. Genes 5%
32. Lymphotoxin-alpha 5%
33. Datasets 5%
34. Alemtuzumab 5%